Ert

Basic Information

9653 Featherwood Lane
Spring Valley, OH, 45370

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 2


  1. Assessment and Rejuvenation of Thermomechanical Fatigue Damaged Metal Matrix Composite Components

    Amount: $598,598.00

    The proposed effort is aimed at developing dual use concepts and techniques for use in rejuvenation of MMC components which contain classical creep-fatigue damage due to thermomechanical service loadi ...

    SBIR Phase II 1996 Army Department of Defense
  2. Assessment and Rejuvenation of Thermomechanical Fatigue Damaged Metal Matrix Composite Components

    Amount: $63,568.00

    N/A

    SBIR Phase I 1995 Army Department of Defense
  3. CRYSTALLOGRAPHIC AREAR DETECTOR SOFTWARE

    Amount: $250,000.00

    N/A

    SBIR Phase II 1992 National Science Foundation
  4. CRYSTALLOGRAPHIC AREAR DETECTOR SOFTWARE

    Amount: $50,000.00

    N/A

    SBIR Phase I 1989 National Science Foundation
  5. THERAPEUTIC ENZYMES FOR DISEASES INVOLVING ACTIVE OXYGEN

    Amount: $444,000.00

    ACTIVE OXYGEN SPECIES ARE IMPLICATED IN MANY DISEASES. ENZON IS IMPROVING THE THERAPEUTIC EFFECTIVENESS OF SUPEROXIDE DISMUTASE AND CATALASE BY OUR PATENTED PROCESS SO THAT THESE ACTIVE OXYGEN-SCAVENG ...

    SBIR Phase II 1988 Department of Health and Human Services
  6. CYTOMEGALOVIRUS DETECTION USING NONRADIOACTIVE DNA PROBES IN SITU

    Amount: $214,000.00

    CYTOMEGALOVIRUS (CMV), A MEMBER OF THE HERPES VIRUS GROUP, IS PRESENT IN THE BLOOD OF A LARGE PORTION OF THE HUMAN POPULATION. ADMINISTRATION OF THIS BLOOD TO HIGH-RISK PATIENTS MAY RESULT IN DEATH. E ...

    SBIR Phase II 1987 Department of Health and Human Services
  7. AMINO ACID-DEGRADING ENZYMES AS ANTICANCER AGENTS

    Amount: $47,000.00

    ENZON, INC. IS INVOLVED IN THE DEVELOPMENT OF THERAPEUTIC ENZYMES FOR HUMAN AND VETERINARY USE. MANY ENZYMES HAVE SHOWN EFFECTIVENESS AS ANTICANCER AGENTS ON INITIAL INJECTION, BUT THEIR IMMUNOGENICIT ...

    SBIR Phase I 1987 Department of Health and Human Services
  8. THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP A THERA- PEUTIC URICASE THAT CAN BE USED IN HYPERURICEMIA AND THE VARIOUS MANIFESTATIONS OF GOUT, INCLUDING ACUTE AND CHRONIC GOUTY ARTHRITIS TOPHI AND URATE DEPOSITS IN TISSUES AND ORGANS, AND URIC ACID

    Amount: $43,000.00

    THE LONG-TERM GOAL OF THIS PROJECT IS TO DEVELOP A THERA- PEUTIC URICASE THAT CAN BE USED IN HYPERURICEMIA AND THE VARIOUS MANIFESTATIONS OF GOUT, INCLUDING ACUTE AND CHRONIC GOUTY ARTHRITIS TOPHI AND ...

    SBIR Phase I 1986 Department of Health and Human Services
  9. CYTOMEGALOVIRUS DETECTION USING NONRADIOACTIVE DNA PROBES IN SITU

    Amount: $50,000.00

    N/A

    SBIR Phase I 1986 Department of Health and Human Services
  10. CYANIDE IS A RAPIDLY ACTING POISON THAT AFFECTS RESPIRATION IN BIOLOGICAL SYSTEMS.

    Amount: $78,625.00

    CYANIDE IS A RAPIDLY ACTING POISON THAT AFFECTS RESPIRATION IN BIOLOGICAL SYSTEMS. VICTIMS MAY DIE IN MINUTES. ENZON, INC. IS THE EXCLUSIVE LICENSEE FOR A PATENTED PROCESS FOR THE CHEMICAL MODIFICATIO ...

    SBIR Phase I 1985 Army Department of Defense

Agency Micro-sites

US Flag An Official Website of the United States Government